Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial

ABSTRACT:

SUBMITTER: Fernandez Fernandez A 

PROVIDER: S-EPMC12384391 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature